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Abstract
Background: SLIT-ROBO families of proteins mediate axon pathfinding and their expression is
not solely confined to nervous system. Aberrant expression of SLIT-ROBO genes was repeatedly
shown in a wide variety of cancers, yet data about their collective behavior in hepatocellular
carcinoma (HCC) is missing. Hence, we quantified SLIT-ROBO transcripts in HCC cell lines, and in
normal and tumor tissues from liver.
Methods: Expression of SLIT-ROBO family members was quantified by real-time qRT-PCR in 14
HCC cell lines, 8 normal and 35 tumor tissues from the liver. ANOVA and Pearson's correlation
analyses were performed in R environment, and different clinicopathological subgroups were
pairwise compared in Minitab. Gene expression matrices of cell lines and tissues were analyzed by
Mantel's association test.
Results: Genewise hierarchical clustering revealed two subgroups with coordinate expression
pattern in both the HCC cell lines and tissues: ROBO1, ROBO2, SLIT1 in one cluster, and ROBO4,
SLIT2, SLIT3 in the other, respectively. Moreover, SLIT-ROBO expression predicted AFP-dependent
subgrouping of HCC cell lines, but not that of liver tissues. ROBO1 and ROBO2 were significantly
up-regulated, whereas SLIT3 was significantly down-regulated in cell lines with high-AFP background.
When compared to normal liver tissue, ROBO1 was found to be significantly overexpressed, while
ROBO4 was down-regulated in HCC. We also observed that ROBO1 and SLIT2 differentiated
histopathological subgroups of liver tissues depending on both tumor staging and differentiation
status. However, ROBO4 could discriminate poorly differentiated HCC from other subgroups.
Conclusion: The present study is the first in comprehensive and quantitative evaluation of SLIT-
ROBO family gene expression in HCC, and suggests that the expression of SLIT-ROBO genes is
regulated in hepatocarcinogenesis. Our results implicate that SLIT-ROBO transcription profile is bi-
modular in nature, and that each module shows intrinsic variability. We also provide quantitative
evidence for potential use of ROBO1, ROBO4 and SLIT2 for prediction of tumor stage and
differentiation status.
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Drosophila slit and roundabout (robo) genes were identified
in genetic screens of mutants for embryonic patterning
and commissural axon pathfinding defects [1]. Subse-
quently, it was shown that SLIT acts as a ligand for ROBO
receptor, preventing axons from recrossing the central
nervous system (CNS) midline, and that this binding is
conserved among vertebrates including mammals [2,3].
In mammals, three SLIT (SLIT1-3) and four ROBO
(ROBO1-4) genes have been described [4,5].
SLIT and ROBO genes are mainly expressed in the CNS
but there are affirmative data that they are also expressed
in non-neuronal tissues, such as mouse lung and kidney
[6,7]. Binding of SLIT2 to ROBO1 inhibits CXCL12-
induced chemotaxis of leukocytes, T cells and monocytes
[8-10]. However, ROBO4 expression has been found to be
confined to vasculature and Robo4 signaling modulates
endothelial cell migration [11].
On the other hand, like other developmental pathways,
aberrant expression of the SLIT-ROBO genes has been
observed in a wide variety of cancers. Mice with targeted
homozygous deletion of first Ig domain of Robo1/Dutt1
died at birth because of abnormal lung development, and
few survivors eventually developed epithelial bronchial
hyperplasia [6]. In breast carcinoma tissue samples
ROBO1 was shown to be overexpressed while SLIT2
induced migration of breast cancer cell lines [12]. SLIT2-
ROBO1 signaling was involved in angiogenesis by
increasing microvessel density and tumor mass in a tumor
xenograft model [13]. In the same study, SLIT2 exhibited
overexpression in tumor cell lines and primary tumors of
a variety of tissues. In contrast, SLIT2 also was proposed
to be a tumor suppressor gene, which was silenced epige-
netically in lung, breast, colon cancers and gliomas [14-
16]. SLIT3 was silenced by promoter hypermethylation in
gliomas and colorectal cancers [17]. SLIT1 and SLIT3 were
overexpressed in prostate tumors [18], whereas along with
SLIT2 they were slightly expressed only in poorly differen-
tiated HCC [19]. CXCL12 was reported to activate the
migration of human melanoma and breast cancer cells
that express CXCR4, ROBO1 and ROBO2, while SLIT2-
ROBO interaction was demonstrated to inhibit chemo-
taxis, chemoinvasion and adhesion of breast cancer cells
[20]. Furthermore, ROBO4 was overexpressed in tumor
endothelial cells in comparison to normal adult endothe-
lial cells [21].
Despite the compiling evidence of SLIT-ROBO deregula-
tion in various tumors, only few reports with apparent
controversies exist with regard to the expression pattern of
these genes in hepatocellular carcinoma (HCC). The over-
expression of ROBO1 in HCC was recently reported and
this receptor was proposed as an HCC marker in humans
[19]. In contrast, another study reported that Robo1 heter-
ozygous mice developed spontaneous HCC tumors [22].
It was shown by immunohistochemical staining that
SLIT2 protein also was present in HCC tumor sections
[13]. Moreover, karyotyping analyses of HCC do not
reveal any chromosomal gains or losses associated with
SLIT-ROBO genes [23,24]. Therefore, in this study, we
quantified SLIT1, SLIT2, SLIT3, ROBO1, ROBO2 and
ROBO4 transcripts in HCC cell lines and tissues. We
observed that SLIT-ROBO genes could be partitioned into
two main clusters based on their expression in either the
HCC cell lines or tissues. SLIT-ROBO expression also clus-
tered the HCC cell lines in two groups according to their
AFP expression pattern. In liver tissues, differential expres-
sion of ROBO1, ROBO4 and SLIT2 was found to be asso-
ciated with clinicopathological parameters such as tumor
staging and differentiation. Herein, we describe a compre-
hensive SLIT-ROBO expression signature in HCC.
Methods
HCC Cell Lines and Tissues
13 hepatoma and 1 hepatoblastoma (HepG2) cell lines
were included in the study and cultured as previously
described [25]. Focus, Hep40, Hep3B, Hep3B-TR, HepG2,
HUH7, Mahlavu, PLC/PRF/5, SK Hep1 cells were cultured
in low-glucose DMEM supplemented with 10% FBS, 100
U/ml Penicillin-Streptomycin, and 0.1 mM non-essential
amino acids (HyClone, Utah, USA). SNU387, SNU398,
SNU423, SNU449, SNU475 cells were cultured in RPMI
1640 medium supplemented with 10% FBS, 100 U/ml
Penicillin-Streptomycin, 0.1 mM non-essential amino
acids (HyClone, Utah, USA). TissueScan Liver Cancer Tis-
sue qPCR Arrays, each containing 40 liver tumor and 8
tumor-adjacent normal tissue cDNAs, were purchased
from Origene Technologies, (Rockville, MD, USA). 5 non-
HCC tumor tissues consisting of 3 cholangiocarcinomas,
1 nodular hyperplasia and 1 liver adenoma were excluded
from the present study. Clinicopathological characteris-
tics of the tissues were presented in Additional file 1.
Primers
PCR primers for human SLITs, ROBO1 and ROBO2 were
previously described [18]. Human ROBO3, ROBO4 and
AFP (alpha-fetoprotein) primers were designed using
Primer3 and targeting exon-exon junctions in order to
prevent amplification of possible contaminating genomic
DNA [26]. Primer sequences were as follows: ROBO3 for-
ward 5'-CAGTGTCCGATGGAAGAAGG-3' and reverse 5'-
GTCCATCTCCTGCACATTGG-3', ROBO4 forward 5'-
GACACTTGGCGTTCCACCTC-3' and reverse 5'-AGAG-
CAAGGAGCGACGACAG-3', AFP forward 5'-AAAT-
GCGTTTCTCGTTGCTT-3' and reverse 5'-
CCAACACCAGGGTTTACTGG-3'. Primer pair for the
housekeeping gene GAPDH (glyceraldehyde-3-phosphate
dehydrogenase) was described before [27]. ACTB (beta-Page 2 of 11
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Cancer Tissue qPCR Array 1 (Origene Technologies, Rock-
ville, MD, USA).
RNA Isolation and cDNA Synthesis
Cell lines were grown to confluency in 100 mm dishes.
Total RNA was extracted using RNeasy Mini Kit (Qiagen,
Hilden, Germany) according to manufacturer's instruc-
tions. cDNA was synthesized with random hexamers from
1 μg of total RNA using DyNAmo™ cDNA Synthesis Kit
(Finnzymes, Espoo, Finland).
Real-time Quantitative RT-PCR Analyses of HCC Cell 
Lines
In cell lines and tissues, the relative expression ratio (R) of
SLIT-ROBO and AFP transcripts (target gene) was meas-
ured based on a modified ΔΔCt formula [28] and normal-
ized to GAPDH or ACTB (reference gene). In
formula, Etarget and Erefreflect PCR efficiencies of the prim-
ers for target genes and reference genes, respectively. PCR
efficiency values for each primer pair was obtained by
constructing a standard curve using threshold cycle (Ct)
values derived from 6 data points, corresponding to 2-fold
decrements of an original cDNA stock (duplicates were
prepared for each dilution). The slope of the resulting
curve was used to calculate the E value of primer pairs
according to E = 2-1/slope formula. PCR efficiencies of the
genes ranged between 1.9 and 2.0. ΔCt was the difference
between the Ct values of controls and samples.
In cell lines, GAPDH was the reference gene. ΔCt values
were obtained by subtracting Ct values of individual genes
(sample) from the average Ct value of all cell lines for that
gene (control). All reactions were performed in duplicates
and repeated at least twice using different batches of RNA
preparations. Relative expression tables were established
by representing ΔΔCt values in log2 base, and in all subse-
quent analyses these values were used.
Quantitative expression analyses were performed using
DyNAmo™ HS SYBR® Green qPCR Kit (Finnzymes, Espoo,
Finland) on an iCycler iQ real-time PCR detection system
(Bio-Rad, Richmond, CA). The PCR reaction was set
according to the manufacturer's recommendations.
Briefly for 1× reaction; 10 μl of 2× SYBR Green PCR Master
Mix, 10 μM forward and reverse primers, and 1 μl of tem-
plate cDNA were mixed in a total volume of 20 μl. After
an initial 15 minutes of denaturation at 95°C, thermal
cycling was performed at 94°C for 30 sec, 60–62°C for 30
sec (optimized for each primer pair), 72°C for 30 sec for
a total of 50 cycles and a final extension step at 72°C for
10 min. In order to validate the production of a single tar-
get-specific PCR product, the amplification was followed
by a melt curve protocol with an initial step at 55°C for 30
sec and 80 repeats of 0.5°C increments with 15 sec dwell
time, from 55°C to 95°C.
Real-time Quantitative RT-PCR Analyses of HCC Tissues
The expression of SLIT-ROBO and AFP genes in HCC was
analyzed using a 96-well plate format TissueScan Liver
Cancer Tissue qPCR Array 1 (Origene Technologies, Rock-
ville, MD), which contained tissue cDNAs normalized
against beta-actin. Real-time PCR protocol was applied as
described by the manufacturer. Briefly, 30 μl of reaction
mix containing 15 μl 2× SYBR Green PCR Master Mix and
10 μM forward and reverse primers was directly added to
PCR-plate wells. Plate was placed on ice for 15 min for
cDNAs to dissolve, and thermal cycling was performed
according to above mentioned protocol. For each gene,
mean Ct value of the normal tissue cDNAs was set as the
control group and relative quantitative expression values
were calculated with the ΔΔCt formula and were repre-
sented in log2 base by taking the ACTB Ct values as refer-
ence.
Statistical Analysis
Using one-way ANOVA in R, mean expression levels of
each gene were compared between high and low AFP
expressing groups of HCC cell lines; and also between
normal and tumor tissues of liver with respect to differen-
tiation or stage [29]. Pairwise comparisons were made
using Fisher's multiple pairwise comparison method in
Minitab® 13.20 Statistical Software (Minitab Inc. 2000).
Furthermore, two-way hierarchical cluster analysis was
used to group cell lines and liver tissues with respect to the
SLIT-ROBO expression patterns using Cluster and
TreeView [30]. Pairwise correlations between SLIT-ROBO
gene expression levels were calculated using Pearson's cor-
relation coefficient. Moreover, a Mantel's association test
was applied to compare cell line and tissue correlation
matrices [29].
Results
QRT-PCR analyses reveal an association between SLIT-
ROBO and AFP expression in HCC cell lines
We first investigated by RT-PCR the presence of SLIT-
ROBO transcripts in 13 HCC and 1 hepatoblastoma cell
lines. All genes were expressed at levels varying from none
to strong after 40 cycles of amplification (Additional file
2). Since HCC cell lines were previously reported to clus-
ter in two main molecular subtypes in terms of their alpha-
fetoprotein (AFP) expression [31] we quantified SLIT-
ROBO gene expression along with AFP transcript levels.
In our first set of qRT-PCR experiments, cell lines with
fibroblastoid morphology, including Focus, Mahlavu, SK
R E ECt control-sample Ct control-= ( ) /( )( ) (target reftarget ref
Δ Δ sample)Page 3 of 11
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SNU475, displayed low-AFP expression, while AFP was
found to be overexpressed in epitheloid Hep40, Hep3B,
Hep3B-TR, HepG2, HUH7 and PLC/PRF/5 cells (Figure
1). Second, we quantified SLIT-ROBO transcripts. ROBO2
and SLIT1 expression were up-regulated in high-AFP
group of cells, except HepG2, which underexpressed
ROBO2 (Additional file 3). On the other hand, both genes
were found to be overexpressed in SNU398, one of the
low-AFP group of cell lines. SLIT3 transcript levels sharply
contrasted those of ROBO2 and SLIT1. Except SNU398,
increased SLIT3 expression was found among low-AFP
expressing group of cell lines, and also in high-AFP
expressing Hep40 cell line. Interestingly, widespread
expression of ROBO1 transcripts that we observed in RT-
PCR turned out to be enhanced in cell lines with high-AFP
background (Additional file 2 and 3). ROBO4 and SLIT2
transcript levels remained variable among HCC cell lines
and no phenotype-based association could be observed
for these genes. Our attempts to calculate PCR efficiency
with two different ROBO3 primer pairs failed, and we dis-
continued qRT-PCR analysis of this gene.
A significant association of gene expression was found
among SLIT-ROBO family genes and AFP based on Pear-
son's pairwise correlation coefficients (Table 1). In partic-
ular, expressions of ROBO1 and SLIT3 were significantly
correlated with that of AFP, in a positive and negative
manner, respectively.
Cluster analyses identify two subgroups in HCC cell lines 
with respect to SLIT-ROBO expression levels
Hierarchical clustering was performed in order to under-
stand whether SLIT-ROBO expression predicts AFP-
dependent grouping of HCC cell lines. In fact, in terms of
SLIT-ROBO expression, low-AFP expressing SNU449,
SNU423, SNU475, Mahlavu, SK Hep1, SNU387, and
Focus cells grouped together (Group I), while high-AFP
expressing HepG2, PLC/PRF/5, HUH7, Hep3B-TR, HEP-
3B and Hep40 cell lines (Group II) clustered separately
from the first group (Figure 2). Exceptionally, SNU398
cell line displayed a SLIT-ROBO expression pattern con-
cordant with Group II despite its low-AFP background.
The expression of AFP significantly differed between the
two groups (p = 0.0001): Mean expression of AFP in
Group I and Group II cells was -4.65 ± 2.75 and 6.20 ±
4.68, respectively.
Hierarchical clustering analysis also revealed a genewise
segregation of SLIT-ROBO genes. Coordinate expression
was observed in two main clusters, one of which grouping
together ROBO1, ROBO2 and SLIT1, and the other
ROBO4, SLIT2, and SLIT3, respectively (Figure 2). We also
performed one-way ANOVA to identify individual SLIT-
ROBO genes, which significantly separate HCC cell lines
with high- and low-AFP expression. We validated that
ROBO1 and ROBO2 expression were up-regulated in
high-AFP group (p = 6.7 × 10-4 and p = 0.013, respec-
tively). Mean expression of ROBO1 in Group I was -1.73
± 2.15 while in Group II cells increased to 2.37 ± 0.48.
Similarly, ROBO2 mean expression values were found as -
2.37 ± 3.31 and 3.11 ± 3.73, for Group I and Group II,
respectively. In sharp contrast, SLIT3 was overexpressed in
cell lines with low-AFP profile (MeanGroupI = 3.28 ± 4.43,
MeanGroupII = -4.24 ± 4.06; p = 6.9 × 10-3).
SLIT-ROBO family expression profile in liver tissues 
correlates with that in HCC cell lines
Next, we addressed the question of whether our cell line
data translate to in vivo conditions. To this end, we quan-
tified the expression of SLIT-ROBO and AFP genes using
cDNAs of 8 tumor-adjacent normal and 35 tumor tissues
(Additional file 4). Accordingly, only ROBO1 was found
to be significantly overexpressed in tumor tissues (Mean-
Normal = 0 ± 0.63, MeanTumor = 1.57 ± 1.63; p = 0.011). We
also observed a down-regulated ROBO4 expression in
tumor tissues with a p-value near significance (MeanNormal
= 0 ± 1.03, MeanTumor = -0.89 ± 1.30; p = 0.079). AFP dis-
played a highly variable expression, yet it was overex-
pressed in more than half of the tumors (18/35)
(Additional file 4).
Hierarchical clustering grouped SLIT-ROBO genes in a
similar manner as in cell lines. ROBO1, ROBO2 and SLIT1
clustered together, whereas ROBO4, SLIT2 and SLIT3
Quantification of AFP transcript levels reveals two groups in HCC cell linesFigure 1
Quantification of AFP transcript levels reveals two 
groups in HCC cell lines. GAPDH normalized AFP expres-
sion was quantified by real-time RT-PCR and expression val-
ues of individual cell lines are calculated relative to the Ct 
average of all cell lines, and represented in log2 base. Samples 
were run in duplicates and the data are representative of two 
independent experiments.Page 4 of 11
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appeared among tissue samples; however, no significant
association of clusters was found with differentiation state
or staging of tumors (Wilcoxon rank sum test) and AFP
expression (one-way ANOVA).
Expression correlation amongst individual SLIT-ROBO
and AFP genes in liver tissues was analyzed by Pearson's
correlation analysis in R (Table 2). Accordingly, expres-
sion of ROBO1 in HCC samples was positively correlated
with that of AFP whereas ROBO4 and AFP were inversely
correlated in terms of their expression. Mantel's permuta-
tion test, performed to compare gene expression correla-
tion matrices of cell lines and tissues (described in Table
1 and Table 2, respectively), indicated that gene-to-gene
correlation patterns in both sample groups were signifi-
cantly associated (r = 0.49; p < 0.02).
ROBO1 expression differentiates normal tissues from 
tumors with respect to both stage and differentiation 
status
We also performed one-way ANOVA followed by Fisher's
multiple pairwise comparisons in order to explore
whether gene expression characteristics of SLIT-ROBO
family members discriminate among liver tissues with
respect to differentiation status and staging of the sam-
ples. The tissue samples lacking stage or differentiation
information in the pathological reports were left out of
analysis. With these criteria, a total of 43 liver tissue sam-
ples for stage and of 38 tissue samples for differentiation
status were analyzed. According to one-way ANOVA,
ROBO1 differentiated liver tissue samples on both the
stage (p = 0.018) and differentiation status (p = 0.031)
dependent manner (Figure 4A, B). ROBO4 expression sig-
nificantly discriminated tissues only with respect to their
differentiation status (p = 0.039) (Figure 4C). Moreover,
Fisher's pairwise comparison analyses revealed that
ROBO1, SLIT2 and ROBO4 significantly discriminated
between different histopathological subgroups both in
terms of differentiation status and/or tumor staging
(Table 3).
Discussion
HCC remains the fifth most common cancer worldwide
and is at the third rank in cancer-caused deaths. The prog-
nosis of patients is generally very poor with a 5-year rela-
tive survival of only 7% [32]. The elucidation of molecular
mechanisms governing hepatocarcinogenesis is therefore
of high priority not only for the better understanding of
the disease, but also to develop more effective therapies.
To achieve this goal, functional genomics studies could
provide valuable information with regard to genes differ-
entially expressed between HCC and normal liver. A col-
lective analysis of expression signature of SLIT-ROBO
family genes has not been assessed yet in liver tumor.
Here, we showed the co-regulation of SLIT-ROBO genes in
HCC. In both the HCC cell lines and liver tissues, ROBO1,
ROBO2, SLIT1, and ROBO4, SLIT2, SLIT3 showed coordi-
nate expression as two distinct modules, yet displaying
high variability at gene level within each module. Addi-
tionally, SLIT-ROBO expression was able to predict AFP
status of HCC cell lines, and thereby establishing two
groups with low- and high-AFP expressions.
Except ROBO3, all genes were found to be expressed at
different levels in our analyses. A preferential up- and
down-regulation of SLIT-ROBO genes occurred depend-
ing on the AFP expression status of HCC cell lines.
ROBO1, ROBO2 and to a lesser extent SLIT1 were overex-
pressed, whereas SLIT3 was underexpressed in high-AFP
Table 1: Genewise correlation of SLIT-ROBO and AFP genes in HCC cell lines
Gene ROBO1 ROBO2 ROBO4 SLIT1 SLIT2 SLIT3 AFP
ROBO1 1
ROBO2 0.6060* 1
ROBO4 -0.2721 -0.2653 1
SLIT1 0.4027 0.7623* -0.3288 1
SLIT2 0.1241 0.1891 0.5143 -0.0039 1
SLIT3 -0.5698* -0.6072* 0.3681 -0.5451* -0.1003 1
AFP 0.6533* 0.5108 -0.3016 0.4579 0.3544 -0.6605* 1
*: p < 0.05Page 5 of 11
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group. However, SLIT2 was expressed in most of the cell
lines, regardless of the AFP expression status.
We also quantified SLIT-ROBO expression in 8 tumor-
adjacent normal liver tissues and 35 HCC tumors. We
found that genewise clustering observed in HCC cell lines
were conserved in tissues: ROBO1, ROBO2, SLIT1 and
ROBO4, SLIT2, SLIT3 were coordinately expressed, respec-
tively. We also noticed two main subgroups in tissue sam-
ples but the observed AFP dependent subgrouping in
HCC cell lines did not translate into the tissue analysis,
except that AFP and ROBO1 expression was significantly
correlated in both HCC cell lines and tissues. This discrep-
SLIT-ROBO expression establishes two groups, which predict AFP expression levels in HCC cell linesFigure 2
SLIT-ROBO expression establishes two groups, which predict AFP expression levels in HCC cell lines. The means 
of normalized expression values of individual SLIT-ROBO genes in each cell line were used to establish the hierarchical clustering 
in Cluster program, and the results were visualized as a heatmap by TreeView. Overexpression and underexpression of indi-
vidual genes relative to Ct average of all cell lines are represented by red and green colors, respectively. Upper single-row heat-
map displays the average expression of all six genes across all cell lines. The tree at the top of the heatmap represents 
samplewise clustering. Based on their AFP expression levels, HCC cell lines are represented in two main subgroups indicated as 
Group I (low-AFP) and Group II (high-AFP) cells. The tree on the left of the heatmap (pink) represents genewise clustering.Page 6 of 11
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HCC cell lines were more homogenous when compared
to tissue samples, which may contain stromal cells,
endothelial cells, immune cells or any other tumor infil-
trating cells. Moreover, our normal liver samples were
tumor-adjacent tissues, which may harbor genetic
changes of tumor microenvironment, and therefore may
not reveal the actual molecular characteristics of a tumor-
free normal liver.
ROBO1 transcript was present in all cell lines that were
examined and it was significantly up-regulated in the ana-
lyzed HCC tissues, in which its overexpression culminated
in later stages and as tumors progress to a less differenti-
ated state. These data were in agreement with a recent
report that demonstrated ROBO1 as an HCC antigen and
proposing it as both a diagnostic marker and therapeutic
target for HCC [19]. SLIT2 was present in most of the
tumor tissues and HCC cell lines although at variable lev-
els. Such variability might explain the clustering of SLIT2
Genewise clustering of SLIT-ROBO genes in HCC cell lines translates into liver tissuesFigure 3
Genewise clustering of SLIT-ROBO genes in HCC cell lines translates into liver tissues. The normalized expression 
values of individual SLIT-ROBO genes in liver tissue samples (n = 43) were used to establish the hierarchical clustering in Cluster 
program and the results were visualized as a heatmap by TreeView. Overexpression and underexpression of individual genes 
relative to Ct average of normal tissues (n = 8) are represented by red and green colors, respectively. Upper single-row heat-
map displays the average expression of all six genes across all tissues. The tree at the top of the heatmap represents sample-
wise clustering, and the tree on the left of the heatmap (pink) represents genewise clustering. T1-35: tumors; N1-8: normal 
tissues; 0: stage 0 (non-tumor); 1, 2, 3A, 4: stage 1, stage 2, stage 3A, stage 4 HCC, respectively; N: tumor-adjacent normal tis-
sue; W: well-differentiated; M: moderately differentiated; P: poorly differentiated; N/A: not-assigned.
Table 2: Genewise correlation of SLIT-ROBO and AFP genes in liver tissues
Gene ROBO1 ROBO2 ROBO4 SLIT1 SLIT2 SLIT3 AFP
ROBO1 1
ROBO2 0.1835 1
ROBO4 -0.1879 -0.2134 1
SLIT1 0.0298 0.002 -0.3793* 1
SLIT2 -0.3679* -0.0078 0.3432* -0.1389 1
SLIT3 -0.0973 -0.0027 0.2596 -0.0965 0.6844*** 1
AFP 0.3679* 0.2324 -0.3699* 0.0924 -0.0769 -0.1638 1
***: p < 0.001; *: p < 0.05Page 7 of 11
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likely to be the main ligand for ROBO receptors. Never-
theless, this does not exclude interactions between other
SLIT and ROBO members, nor it does the possible ligand-
independent activities of ROBO receptors in HCC. Addi-
tionally, SLIT2 and ROBO1 were both upregulated in
HCCs with advanced stages and poor differentiation sta-
tus (Figure 3 and Table 3). These findings also are in agree-
ment with the expression of SLITs specifically in poorly
differentiated HCCs [19]. Furthermore, in a tumor
xenograft model, SLIT2-ROBO1 signaling was shown to
have a role in angiogenesis, which supports tumor growth
and metastasis [13].
Although ROBO4 was shown to be specific to vasculature
[11], we observed varying levels of ROBO4 transcript in
HCC cell lines. The ROBO4 transcripts in these cells might
be partly explained by the presence of side population
cells with stem cell characteristics that express markers of
the vascular endothelium [33]. One may also consider a
possible regulation of ROBO4 expression in liver tumors.
In tissue expression analyses, we found that ROBO4
ROBO1 and ROBO4 expression discriminate between different stage and differentiation groups of liver tissuesFigure 4
ROBO1 and ROBO4 expression discriminate between different stage and differentiation groups of liver tissues. 
Expression values of SLIT-ROBO genes were compared using one-way ANOVA in liver tissue samples that are stratified accord-
ing to their stages and differentiation status and represented as boxplots. (A) ROBO1 significantly differentiates one staging 
group from the others (p = 0.018). (B) The expression of ROBO1 also discriminates between different differentiation status of 
liver tissues (p = 0.031). (C) ROBO4 also significantly separates one differentiation group among all (p = 0.039).Page 8 of 11
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ferentiated tumors, indicating that ROBO4 function is not
essential for the maintenance of tumor at this step of
hepatocarcinogenesis. In fact, recent findings indicated
that SLIT2-ROBO4 interactions inhibited angiogenesis
[34].
It is very likely that SLIT2-ROBO1-ROBO4 might contrib-
ute to some of the variability associated with the differen-
tiation status of HCC while expression of ROBO1 and
SLIT2 also helps explain the stage differences in this can-
cer. However, the expression variability is high among
liver tumors suggesting that a combinatorial code with a
possibility of ligand redundancy might be at work in
hepotocellular carcinoma, which prompts further func-
tional studies that include knock-down and overexpres-
sion.
A global gene expression analysis by microarray technol-
ogy in 19 HCC cell lines revealed two molecular subtypes
depending on their AFP expression level [31]. Of 14 HCC
cell lines that we studied, 13 were included in that study
and the SLIT-ROBO dependent subgrouping in our analy-
sis was parallel to the AFP subgrouping previously
observed, verifying the reliability of our cell line panel.
ROBO1 and SLIT3 were the genes that were most signifi-
cantly correlated with AFP expression in a positive and
negative manner, respectively. Genes regulating extracel-
lular matrix establishment or remodeling and cell adhe-
sion were shown to be differentially expressed between
the HCC cell line subgroups [31]. Cells that were defined
to be more metastatic and motile correspond to cell lines
that cluster as Group I in our study. Given the important
roles of SLIT-ROBO associated signaling molecules like
ENA, ABL, and several GTPase activating proteins in
Table 3: Differentially expressed SLIT-ROBO genes between histopathological subgroups of liver tissues
Stage n Mean expression (SE) Differentially expressed gene*
0 8 0 (0.22) ROBO1
2 11 2.37 (0.41)
0 8 0 (0.22) ROBO1
3 13 1.43 (0.57)
1 9 0.79 (0.33) ROBO1
2 11 2.37 (0.41)
2 11 -2.29 (1.15) SLIT2
3 13 -0.96 (0.44)
Differentiation state n Mean expression (SE) Differentially expressed gene*
Normal 8 0 (0.22) ROBO1
Moderate 16 1.89 (0.44)
Normal 8 0 (0.22) ROBO1
Poor 6 1.84 (0.60)
Normal 8 0 (0.36) ROBO4
Poor 6 -2.02 (0.80)
Well 8 -0.60 (0.43) ROBO4
Poor 6 -2.02 (0.80)
Moderate 16 -0.66 (0.25) ROBO4
Poor 6 -2.02 (0.80)
Moderate 16 -1.28 (0.78) SLIT2
Poor 6 1.01 (0.88)
* Pairs of stage and differentiation subgroups were compared in Fisher's pairwise comparison analysis and only the genes that significantly 
discriminate between subgroups were represented (p < 0.05). SE: standard error.Page 9 of 11
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connection between SLIT-ROBO signaling and HCC
tumor cell invasion and metastasis remains to be further
described.
Conclusion
Here, we defined the overexpression of ROBO1 and the
variable expression of other SLIT-ROBO family members
in HCC. Especially, downregulation of ROBO4 and upreg-
ulation of SLIT2 mark late stage and poorly differentiated
HCCs. We have also shown that the collective expression
of these genes occurs in a coordinated fashion in two
main groups suggesting that SLIT-ROBO signaling is mod-
ular in nature, and that each module shows intrinsic vari-
ability. Our results help increase our understanding of
pathological expression pattern of SLIT-ROBO family in
HCC with potential for diagnostic applications. Elucida-
tion of the mechanisms acting on the transcriptional reg-
ulation of SLIT-ROBO signaling pathway, such as
alternative splicing, copy number variability and ligand/
receptor redundancy in both HCC and other pathophysi-
ological contexts will contribute to a better understanding
of hepatocarcinogenesis.
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